Compare Heron Therapeutics Inc (HRTX) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs PulteGroup, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while PulteGroup, Inc. trades at $123.34 (market cap $23.46B). The key difference: PulteGroup, Inc. is far larger — about 256.5× Heron Therapeutics Inc's market cap, and PulteGroup, Inc. pays a 0.84% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PHM | |
|---|---|---|
Market Cap | $91.46M | $23.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.96 | $142.56 |
52-Week Low | $0.39 | $108.65 |
Enterprise Value | $189.36M | $23.42B |
Dividend Yield | — | 0.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
